Lexeo Therapeutics Inc

The current institutional shareholding score of Lexeo Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 112.72%, representing a quarter-over-quarter increase of 25.76%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 1.90M shares, representing 2.27% of shares outstanding, with 43.95% decrease in holdings.